hyetellose + sodium chloride: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
hyetellose + sodium chloride: clinical details
Prescribing considerations
- Confirm symptoms are consistent with dry eye related to deficient tear secretion; assess persistent, unilateral or red-flag symptoms.
- Warn about transient stinging or blurred vision and advise waiting until vision is clear before driving.
- Stop treatment and reassess if irritation worsens, persists or is accompanied by continuing redness.
- No routine laboratory monitoring is specified.
Contraindications and cautions
- Hypersensitivity to hyetellose, sodium chloride, borax, boric acid or another formulation component.
Monitoring
- Clinical response and ocular comfort
- Persistent irritation or redness
- New pain, photophobia or visual change
Clinical pharmacology
Hyetellose provides viscolising and lubricating effects. With sodium chloride, it acts as an artificial tear and has increased tear-film break-up time in animal models. Conventional systemic pharmacokinetic assessment is not applicable.
Formulation and product differences
- Clear, colourless sterile ophthalmic solution.
- Preservative-free single-use units.
- Excipients include purified water, borax and boric acid.
- Discard each unit after one use; protect from light and freezing.
hyetellose + sodium chloride interactions
No interactions with other medicines are known for this product.
Sources
These sources were used to prepare and review this medicine page.
iatroX CPD
Keep a note for CPD
Save a private reflection with this source attached. Your first is free.
Record learning (opens in a new tab)Prepared and reviewed by the iatroX editorial team.